Skin Therapy Luminous Gluta SPF50+ is a brightening and protective body lotion formulated to hydrate, even skin tone, and shield the skin from harmful UV rays
The Europe GLP-1 market is projected to record substantial growth during the forecast period
The US Food and Drug Administration and the European Medicine Agency approve semaglutide under three distinct formulations
Oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in multiple sclerosis: focus on certain exogenous and endogenous Nrf2 activators and therapeutic plasma exchange modulation
Semaglutide was first developed and approved as a diabetes drug, giving it a strong market foothold
However, in genetically predisposed individuals, a subset of autoreactive T cells can evade these mechanisms, become activated, proliferate, and differentiate, initiating an autoimmune cascade (Fig